Literature DB >> 32531246

A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver".

Chengqian Yin1, Bo Zhu2, Xin Li2, Colin R Goding3, Rutao Cui4.   

Abstract

Entities:  

Year:  2020        PMID： 32531246     DOI： 10.1016/j.cell.2020.04.029

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  4 in total

Review 1.  MHC Class III RNA Binding Proteins and Immunity.

Authors:  Geraldine Schott; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2020-12-20       Impact factor: 4.652

2.  Annotation matters: validating the discovery of cancer drivers.

Authors:  Marta Rodríguez-Martínez; Jesper Q Svejstrup
Journal:  Mol Cell Oncol       Date:  2020-08-31

Review 3.  Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators.

Authors:  Yuran Qiu; Yuanhao Wang; Zongtao Chai; Duan Ni; Xinyi Li; Jun Pu; Jie Chen; Jian Zhang; Shaoyong Lu; Chuan Lv; Mingfei Ji
Journal:  Acta Pharm Sin B       Date:  2021-02-25       Impact factor: 11.413

4.  Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver.

Authors:  Marta Rodríguez-Martínez; Thierry Boissiére; Melvin Noe Gonzalez; Kevin Litchfield; Richard Mitter; Jane Walker; Svend Kjœr; Mohamed Ismail; Julian Downward; Charles Swanton; Jesper Q Svejstrup
Journal:  Cell       Date:  2020-06-11       Impact factor: 41.582
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.